<DOC>
	<DOCNO>NCT01825317</DOCNO>
	<brief_summary>Non-invasive stimulation brain use magnetic cognitive stimulation computer treatment Alzheimer patient .</brief_summary>
	<brief_title>Effect NeuroAD Alzheimer Patients</brief_title>
	<detailed_description>Synchronized TMS cognitive training treatment mild moderate Alzheimer 's patient . Treatment deliver 5 day week , 6 week , visit hour long . Evaluation neuropsychological evaluation 6 week .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>1 . Male female age 6090 year 2 . Patients diagnose mild moderate stage Alzheimer 's Disease , accord DSMIV criterion . 3 . MMSE score 18 26 4 . Adascog 17 5 . Physically acceptable study confirm medical history exam . 6 . Spouse , family member professional caregiver agree capable take care responsible participation patient study ( answer question regard patient 's condition assume responsibility medication ) 7 . Agreement participate approximately 14 week study . 8 . Normal correct normal ability see hear . 9 . Korean primary language 10 . 8th grade education minimum 1 . CDR 0 3 2 . Severe agitation ; 3 . Mental retardation ; 4 . Patient lack capacity consent study participation 5 . Unstable medical condition ; 6 . Use benzodiazepine barbiturate study precede two week ; 7 . Pharmacological immunosuppression ; 8 . Participation clinical trial investigational agent within two week prior study enrollment ; 9 . History Epileptic Seizures Epilepsy ; 10 . Contraindication perform MRI scanning ; 11 . Contraindication receive TMS treatment accord TMS questionnaire ; 12 . Pregnant woman , woman ability become pregnant unless acceptable method contraception study . 13 . Patients personal history clinically define neurological disorder , include organic brain disease , epilepsy , stroke , brain lesion , multiple sclerosis ; personal history previous neurosurgery head trauma result loss consciousness . 14 . Patients depression , bipolar disorder psychotic disorder neurological psychiatric condition ( whether past ) , Investigator find interfere study 15 . Alcoholism drug addiction define DSMIV within last 5 year ( addict one year remission le 3 year ) severe sleep deprivation 16 . Patients treat cholinesterase inhibitor , memantine Ginkobiloba allow participate , treatment start least 6 month previous recruitment . The patient keep dose medication whole trial prior study begin . 17 . Patients metal head , except mouth ( i.e . cochlear implant , implant brain stimulators , aneurysm clip ) 18 . Patients increase intracranial pressure 19 . Cardiac pacemaker 20 . Implanted neurostimulators 21 . Implanted medication pump 22 . Intracardiac line 23 . Significant heart disease 24 . Currently take medication low seizure threshold 25 . Significant sleep deprivation alcoholism</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>TMS</keyword>
	<keyword>NeuroAd</keyword>
	<keyword>cognitive training</keyword>
	<keyword>ADAS-Cog</keyword>
</DOC>